Skip to content
Emami logo

Emami

EMAMILTD NSE
₹381.35 No trade today
P/E
22.24
View as Markdown
MCP
Close 4 Nov 2026 ₹381.35 −141.65 −27.1% 1Y
Start ₹523.00

Key Fundamentals

SmallcapPersonal ProductsFMCG

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
28.10%
Debt to Equity
0.06
EPS (TTM)
₹17.15
Book Value
₹66.99
Market Cap
—
P/E (TTM)
22.24
P/B
5.69
ROE
26.20%
Dividend Yield
2.62%
EBITDA
₹1,049 Cr
52W High
₹550.90
52W Low
₹357.00
Volume
0

Peer Comparison

Fast Moving Consumer Goods › Consumer Goods › Personal Care

Emami peer comparison
Godrej Consumer Products
₹849.0045.38₹86,648 Cr6.891.82%16.10%18.80%₹15,949 Cr₹1,914 Cr
Dabur India
₹395.0035.52₹69,681 Cr6.142.16%17.00%20.30%₹13,552 Cr₹1,947 Cr
Colgate Palmolive
₹1,660.7033.17₹45,422 Cr27.921.47%82.70%108.00%₹6,391 Cr₹1,362 Cr
Cupid
₹336.50329.90₹44,683 Cr100.451.48%27.60%33.90%₹484 Cr₹137 Cr
Gillette
₹7,527.0036.71₹23,745 Cr25.923.32%66.50%90.70%₹3,176 Cr₹668 Cr
P&G Hygiene and Health Care
₹6,959.0028.57₹22,555 Cr29.983.61%115.00%157.00%₹4,245 Cr₹790 Cr
Emami (this company)
₹381.3522.24₹16,773 Cr5.692.62%26.20%28.10%₹3,915 Cr₹749 Cr
Median 7 companies₹849.0035.52₹44,683 Cr25.922.16%27.60%33.90%₹4,245 Cr₹790 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

56 Good

Data confidence 100/100

Category scores

Quality
82
Strong
Returns, margins, earnings quality 22% weight
Valuation
49
Average
Cheap vs sector & own history 24% weight
Growth
39
Weak
Sales & profit trajectory 9% weight
Financial Health
90
Strong
Solvency, leverage, coverage 9% weight
Momentum
35
Poor
Trend strength, vol-adjusted 12% weight
Ownership
48
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
  • Company has been maintaining a healthy dividend payout of 52.9%
  • Debtor days have improved from 42.3 to 33.2 days.

Weaknesses

2
  • The company has delivered a poor sales growth of 5.58% over past five years.
  • Tax rate seems low

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBullish658
OscillatorsNeutral252
Moving AveragesStrong Bullish406

Key readings

RSI (14)
54.52
Neutral
MACD (12,26,9)
−1.03
Bullish
SMA (50)
376.45
Bullish
SMA (200)
419.06
Bearish

As of

Analyst Rating

Based on 21 analysts
BUY86%

18 of 21 analysts rate Buy, 3 Hold, 0 Sell.

As of

BUY
18
86%
HOLD
3
14%
SELL
0
0%

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+4.83%
5Y+5.58%
3Y+3.53%
1Y−0.76%
TTM+2.84%

Net profit

Net profit growth by window
10Y+7.88%
5Y+11.24%
3Y+7.32%
1Y−3.49%
TTM−8.21%

Operating cash flow

Operating cash flow growth by window
10Y+3.61%
5Y−2.77%
3Y+2.26%
1Y−10.60%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−3.78 pp
5Y−5.14 pp
3Y+0.30 pp
1Y−1.22 pp
TTM−1.73 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹2,488 Cr
Mar 2018₹2,531 Cr
Mar 2019₹2,695 Cr
Mar 2020₹2,655 Cr
Mar 2021₹2,881 Cr
Mar 2022₹3,192 Cr
Mar 2023₹3,406 Cr
Mar 2024₹3,578 Cr
Mar 2025₹3,809 Cr
Mar 2026₹3,780 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹340 Cr
Mar 2018₹306 Cr
Mar 2019₹303 Cr
Mar 2020₹302 Cr
Mar 2021₹455 Cr
Mar 2022₹837 Cr
Mar 2023₹627 Cr
Mar 2024₹724 Cr
Mar 2025₹803 Cr
Mar 2026₹775 Cr

Analyst Forecasts

Forecast For
Sep 26 consensus · EBITDA
₹204 Cr −16.2% vs Jun 26
Reported High Mean Low

AI Analysis — Bull vs Bear

Figures as of 2 Nov 2026
AI opinion · based on fundamentals
Risk medium

Emami Ltd trades at ₹372.2 as of 2026-11-02 with a market cap of ₹15,975.9 crore, a trailing P/E of 21.7x, and ROE of 26.53%. The company is virtually debt-free (debt-to-equity of 0.06) and maintains a strong dividend payout, but faces headwinds from declining profitability on a TTM basis and a stock price that sits near its 52-week low of ₹357, down sharply from its 52-week high of ₹550.9.

Bull Case 7
  • Nearly debt-free balance sheet with a debt-to-equity ratio of just 0.06, providing significant financial flexibility and low interest burden.
  • Consistently high return on equity — 3-year average ROE of 28% and 5-year average of 31% — indicating efficient capital allocation and strong profitability relative to equity.
  • ROCE of 28.59% as of 2026-11-02 reflects robust returns on total capital employed, well above the cost of capital for most FMCG firms.
  • Healthy dividend yield of 2.78% supported by a dividend payout ratio of 52.9%, offering meaningful income to shareholders.
  • Improvement in debtor days from 42.3 to 33.2 days signals better working capital management and faster cash conversion from receivables.
  • 5-year compounded profit growth of 11% outpaces 5-year sales growth of 6%, suggesting margin expansion and operational leverage over the medium term.
  • Price-to-book ratio of 5.56x, while optically high, is underpinned by the company's consistent ROE in the mid-to-high 20s, which can justify premium valuations in the consumer goods space.
Bear Case 8
  • TTM profit growth has turned negative at -7%, marking a reversal from the 5-year compounded profit growth of 11% and raising concerns about near-term earnings momentum.
  • Stock price has declined 32% over the past 1 year and delivered a negative CAGR of -4% over 10 years, indicating persistent long-term value destruction for equity holders.
  • Compounded sales growth of just 5% over 10 years and 4% over 3 years points to structural top-line stagnation in a sector where peers have grown faster.
  • Current price of ₹372.2 is just 4.1% above the 52-week low of ₹357 and 32.4% below the 52-week high of ₹550.9, reflecting sustained negative sentiment.
  • 3-year stock CAGR of -11% and 5-year CAGR of -8% suggest the market has been de-rating the stock over multiple time horizons despite steady ROE.
  • TTM sales growth of only 3% in a consumer goods business barely keeps pace with inflation, implying negligible real volume growth.
  • The effective tax rate appears low, which could normalise upward in future periods and compress reported earnings.
  • 10-year compounded profit growth of 6% against a 10-year ROE averaging 26% suggests a significant portion of returns has been paid out rather than reinvested for compounding, limiting book value growth.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

9h ago

TL;DR: Limited news flow for Emami with only a promoter share pledge reshuffling event. The net reduction of 19.6 lakh encumbered shares is a mildly encouraging sign of easing promoter leverage, though the overall pledge level remains worth monitoring. No operational or earnings-related catalysts are visible in this period.

Neutral 1
  • Promoter pledge activity nets lower Oct 30

    Diwakar Finvest released 41 lakh Emami shares from Bajaj Finance pledge while Suraj Finvest pledged 21.4 lakh shares to ICICI Bank, resulting in a net decrease of 19.6 lakh encumbered shares as disclosed on October 30, 2026.

Quarterly Results

₹ Cr
EMAMILTD quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
826
865
996
891
906
891
1,049
963
904
799
1,152
925
1,039
Expenses
636
632
682
682
692
645
715
744
692
622
768
739
815
Operating Profit
190
233
314
209
214
246
334
219
212
177
384
186
225
OPM %
23%
27%
32%
24%
24%
28%
32%
23%
23%
22%
33%
20%
22%
Other Income
8
11
11
11
10
22
15
21
22
21
9
23
18
Interest
2
2
3
3
2
2
2
3
2
3
3
3
6
Depreciation
46
46
46
48
44
45
46
44
44
45
45
42
43
PBT
150
196
276
169
178
220
301
194
187
150
345
164
195
Tax %
9%
8%
6%
13%
16%
4%
7%
16%
12%
1%
7%
13%
29%
Net Profit
137
180
261
147
151
211
279
162
164
148
319
143
139
EPS (₹)
3.14
4.09
5.92
3.41
3.5
4.87
6.39
3.72
3.76
3.4
7.32
3.28
3.15

Profit & Loss

₹ Cr
EMAMILTD profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
2,076
2,358
2,488
2,531
2,695
2,655
2,881
3,192
3,406
3,578
3,809
3,780
3,915
Expenses
1,536
1,670
1,729
1,812
1,970
1,970
2,000
2,254
2,550
2,632
2,796
2,820
2,943
Operating Profit
541
688
759
719
725
685
880
938
855
946
1,014
960
972
OPM %
26%
29%
31%
28%
27%
26%
31%
29%
25%
26%
27%
25%
25%
Other Income
91
44
31
19
25
46
69
90
69
41
68
75
72
Interest
5
54
58
34
21
21
13
5
7
10
9
11
14
Depreciation
34
255
309
311
325
336
367
335
247
186
178
177
176
PBT
592
423
424
393
403
374
569
688
670
791
894
846
854
Tax %
18%
14%
20%
22%
25%
19%
20%
−22%
6%
8%
10%
8%
—
Net Profit
485
363
340
306
303
302
455
837
627
724
803
775
750
EPS (₹)
10.7
8
7.5
6.77
6.68
6.67
10.23
19.02
14.5
16.58
18.48
17.76
17.15
Div. Payout %
33%
44%
47%
52%
60%
60%
78%
42%
55%
48%
54%
56%
—

Balance Sheet

₹ Cr
EMAMILTD balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
23
23
23
23
45
45
44
44
44
44
44
44
Reserves
1,208
1,589
1,732
1,991
2,031
1,778
1,718
2,032
2,259
2,403
2,651
2,880
Borrowings
36
671
473
326
110
210
101
282
91
94
90
162
Other Liabilities
410
409
376
458
633
644
656
692
703
728
741
745
Total Liabilities
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Fixed Assets
453
1,918
1,994
1,802
1,680
1,459
1,132
1,344
1,245
1,114
984
886
CWIP
29
67
22
30
36
8
6
3
6
8
15
1
Investments
501
104
128
314
187
156
255
303
293
442
676
834
Other Assets
693
604
460
652
915
1,055
1,126
1,400
1,551
1,706
1,850
2,108
Total Assets
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831

Cash Flow

₹ Cr
EMAMILTD cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
534
562
730
588
554
531
922
644
749
779
896
801
Investing
−237
−1,313
−306
−276
−26
−231
−224
−234
−122
−210
−345
−174
Financing
−215
502
−496
−324
−428
−405
−688
−402
−608
−563
−500
−554
Net Cash Flow
82
−249
−72
−12
100
−106
9
8
19
6
52
72
Free Cash Flow
426
430
448
465
421
383
890
164
719
750
852
770
CFO/OP
116
96
105
93
89
89
115
84
101
98
107
101

Ratios

EMAMILTD financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
18
20
14
22
29
42
29
37
44
50
43
33
Inventory Days
59
68
83
87
88
102
118
121
100
102
94
128
Days Payable
90
112
85
109
115
135
138
138
124
143
133
153
Cash Conversion Cycle
−13
−24
12
1
2
9
10
19
20
9
4
8
Working Capital Days
−16
−54
−62
−32
−6
7
−3
0
28
30
25
21
ROCE %
61%
30%
23%
22%
19%
18%
29%
31%
28%
32%
32%
28%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Emami insights

77 extracted metrics across FY11–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 54.84%
  • DIIs 23.58%
  • FIIs 9.02%
  • Others 6.32%
  • Public 6.24%

15.06% of promoter holding pledged as of Sep 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Emami

What does Emami Ltd do?
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.
Where is Emami Ltd (EMAMILTD) listed?
Emami Ltd trades as EMAMILTD on the NSE and under code 531162 on the BSE.
Which sector does Emami Ltd belong to?
Emami Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the PE ratio of Emami Ltd?
Emami Ltd trades at a PE ratio of 22.24 as of 4 Nov 2026, on earnings per share of ₹17.15, against a book value of ₹66.99 per share.
What is the 52-week high and low of Emami Ltd?
Over the last 52 weeks Emami Ltd has traded between ₹357 and ₹550.9 as of 4 Nov 2026.
Does Emami Ltd pay dividends?
Emami Ltd has a dividend yield of 2.62%.
What is the Return on Equity (ROE) of Emami Ltd?
Emami Ltd reported a return on equity of 26.20%. Its debt-to-equity ratio is 0.06.

Company Information

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.

Website emamiltd.in
CEO Mr. Radhe Shyam Goenka B.Com., L.L.B., M.Com. LLB
Employees 3,217
Listed 3 Aug 2006
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/EMAMILTD.md for Emami Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Personal Care stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month